22Jan
Blog: Cooley’s 2020 Life Sciences M&A Year in Review
General Trends in Life Sciences M&A - If 2019 was the year of life sciences mega-deals, 2020 was the year of COVID-19, as the global pandemic permeated every aspect of the dealmaking landscape, with the life sciences sector being no exception. COVID-19 drove unprecedented levels of collaboration among biopharmaceutical companies seeking to develop a vaccine, leading to an accelerated research and development process that allowed not just one—but two—vaccines to be approved by the FDA in...
By:
Cooley LLP
Related
The Use of "Time is of the Essence" Clauses in Commercial Real Estate Repurchase Options - In Di Mi...
Read More >
As states and other jurisdictions continue to implement, amend, and clarify their stay-at-home order...
Read More >
North Carolina recently amended the statute that governs the process by which general contractors on...
Read More >
Welcome to the Great Women in Compliance Podcast, co-hosted by Lisa Fine and Mary Shirley. In this e...
Read More >
Tax laws have long required that qualified retirement plans timely adopt written plan documents and ...
Read More >
Pursuant to 29 C.F.R. § 1910.134(f) employees are required to be fit tested prior to wearing tight-f...
Read More >